Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

2.4K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503
Amyloid Fibrils03:03

Amyloid Fibrils

11.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils03:03

Amyloid Fibrils

6.2K
6.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The collection of speech data for the assessment of cognition remotely: Balancing ethical and practical challenges.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Spiro-Linked Polyketides from Cultures of <i>Westerdykella dispersa</i> Ca4-13 as Inhibitors of iNOS-Associated Neuroinflammation.

Journal of natural products·2026
Same author

Benzydamine Attenuates Matrix Metalloproteinase-9 Expression Through Inhibition of ERK MAPK in Activated Human Monocytic Cells Under Hyperglycemic Condition.

Mediators of inflammation·2026
Same author

Evaluating physicians' teaching perspectives and demonstration of core competencies in clinical shadowing.

BMC medical education·2025
Same author

Aging-associated immune signature as a predictor of mortality in end-stage renal disease: results from the longitudinal iESRD study.

Immunity & ageing : I & A·2025
Same author

Anti-herpetic treatment reduces dementia risk: A systematic review and meta-analysis.

Journal of Alzheimer's disease : JAD·2025
Same journal

Stage-dependent relationship between sleep duration and cortical tau deposition in cognitively impaired individuals: A cross-sectional study.

Journal of Alzheimer's disease : JAD·2026
Same journal

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same journal

The creation and verification of a detection model for mild cognitive impairment by employing eye-tracking and gait metrics.

Journal of Alzheimer's disease : JAD·2026
Same journal

Compartment-specific analysis reveals disrupted astrocytic calcium transients in anesthetized Alzheimer's disease mice.

Journal of Alzheimer's disease : JAD·2026
Same journal

<i>APOE</i> ε4-specific associations between agitation, cerebrospinal fluid biomarkers, and cognitive decline in cognitively impaired patients.

Journal of Alzheimer's disease : JAD·2026
Same journal

Depressive-cognitive interactions modulate amygdala and hippocampus functional connectivity in mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 8, 2026

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.5K

Relación entre la carga de amiloide, la integridad colinérgica y la función cognitiva

Li-Hua Lee1, Chia-Ju Chou1, Yao-Chia Shih2

  • 1Department of Neurology, Cardinal Tien Hospital, New Taipei City, Taiwan.

Journal of Alzheimer's disease : JAD
|December 22, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La integridad de la sustancia blanca colinérgica está relacionada con la acumulación de amiloide en la enfermedad de Alzheimer temprana, lo que afecta la función cognitiva. Esta asociación es más evidente en los no portadores del gen de la apolipoproteína E4.

Palabras clave:
Enfermedad de Alzheimercarga de amiloideportador de apolipoproteína E4integridad colinérgicacognición

Más Videos Relacionados

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.6K
Intracerebroventricular Injection of Amyloid-&#946; Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

44.1K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.5K
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.6K
Intracerebroventricular Injection of Amyloid-&#946; Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

44.1K

Área de la Ciencia:

  • Neurociencia
  • Radiología
  • Gerontología

Sus antecedentes:

  • La acumulación de amiloide y la degeneración de la sustancia blanca colinérgica son características de la enfermedad de Alzheimer (EA) temprana.
  • La relación precisa entre la carga de amiloide y la integridad de la vía colinérgica en la patogénesis de la EA no se comprende completamente.

Objetivo del estudio:

  • Investigar la asociación entre la acumulación de amiloide, la integridad de la vía de la sustancia blanca colinérgica y el rendimiento cognitivo en la EA temprana.
  • Explorar cómo el genotipo de la apolipoproteína E4 (APOE4) influye en estas relaciones.

Principales métodos:

  • Estudio transversal de 109 participantes (37 controles, 72 EA temprana).
  • Pruebas neuropsicológicas (MMSE, CDR-SB, fluidez verbal).
  • Imagen por tensor de difusión (DTI) para la integridad de la sustancia blanca colinérgica e imagen por tomografía por emisión de positrones (PET) de amiloide para la carga de amiloide.

Principales resultados:

  • La carga de amiloide y la integridad colinérgica se asociaron de forma independiente con el rendimiento cognitivo en todos los participantes.
  • En la EA temprana, la carga de amiloide se correlacionó con el MMSE y la integridad colinérgica se correlacionó con todas las medidas cognitivas.
  • La carga de amiloide y la integridad colinérgica se correlacionaron significativamente solo en los no portadores de APOE4.

Conclusiones:

  • La integridad de la sustancia blanca colinérgica, influenciada por la carga de amiloide, puede servir como biomarcador de imagen específico para la enfermedad de Alzheimer temprana.
  • Esta asociación es particularmente pronunciada en individuos sin la variante genética APOE4.